Courage To Continue
Courage to Continue is dedicated to empowering individuals, overcoming trauma, and encouraging social change through thought-provoking films and public service announcements, and public speaking.
Patient Safety Impact
Patient Safety Impact works in partnership with established consumer advocacy groups and agencies whose work centers around patient safety. Its focus is on healthcare, patient engagement, patient safety, and navigating through a flawed medical system.
Community Impact works with local community and national organizations focusing on nursing homes, domestic violence, sexual violence, mental health, and homelessness.
Rachel Brummert is Founder and CEO of Courage to Continue, LLC and serves as a Special Government Employee (SGE) at the U.S. Food and Drug Administration. She is also a contributor at Drugwatch and Medshadow Foundation. Additionally, she is Communications Lead at American Society of Pharmacovigilance and founding member of the STRIPE Initiative. Most recently, she became a Steering Committee Member for Personalized Medicine Coalition's More Than a Number campaign.
Rachel began her journey in healthcare advocacy in 2006 when she suffered permanent adverse reactions from a commonly prescribed antibiotic called Levaquin. She used her experience as a harmed patient to advocate for others and works in partnership with established consumer advocacy groups and agencies whose work centers around patient safety. She collaborates with the Centers for Disease Control and Prevention (CDC), and her patient safety work has been featured in Consumer Reports, Washington Post, Web MD, and television media.
She uses her passion for being a voice for the voiceless through filmmaking, and public speaking.
Rachel earned her Bachelor of Science from Cabrini University in Special Education and her Master of Science from Rutgers University in Substance Abuse Counseling.
Originally from East Brunswick, New Jersey she now resides in Charlotte, North Carolina with her husband and two dogs.